Skip to main content

. 1965 Dec;44(12):1945–1952. doi: 10.1172/JCI105300

Significance of bacterial variants in urine of patients with chronic bacteriuria.

L T Gutman, M Turck, R G Petersdorf, R J Wedgwood

PMCID: PMC289696 PMID: 4954866

1946

Images in this article

Image
on p.1948

Image
on p.1948

Image
on p.1948

Image
on p.1948

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

ALDERMAN M. H., FREEDMAN L. R. EXPERIMENTAL PYELONEPHRITIS. X. THE DIRECT INJECTION OF E. COLI PROTOPLASTS INTO THE MEDULLA OF THE RABBIT KIDNEY. Yale J Biol Med. 1963 Oct;36:157–164. [PMC free article] [PubMed] [Google Scholar]
BRAUDE A. I., SIEMIENSKI J., JACOBS I. Protoplast formation in human urine. Trans Assoc Am Physicians. 1961;74:234–245. [PubMed] [Google Scholar]
DIENES L., WEINBERGER H. J., MADOFF S. The transformation of typhoid bacilli into L forms under various conditions. J Bacteriol. 1950 Jun;59(6):755–764. doi: 10.1128/jb.59.6.755-764.1950. [DOI] [PMC free article] [PubMed] [Google Scholar]
Dienes L. Morphology and Nature of the Pleuropneumonia Group of Organisms. J Bacteriol. 1945 Oct;50(4):441–458. [PMC free article] [PubMed] [Google Scholar]
EDWARD D. G., FREUNDT E. A. The classification and nomenclature of organisms of the pleuropneumonia group. J Gen Microbiol. 1956 Feb;14(1):197–207. doi: 10.1099/00221287-14-1-197. [DOI] [PubMed] [Google Scholar]
GUZE L. B., KALMANSON G. M. ACTION OF ERYTHROMYCIN ON "PROTOPLASTS" IN VIVO. Science. 1964 Dec 4;146(3649):1299–1300. doi: 10.1126/science.146.3649.1299. [DOI] [PubMed] [Google Scholar]
Guze L. B., Kalmanson G. M. Persistence of Bacteria in "Protoplast" Form after Apparent Cure of Pyelonephritis in Rats. Science. 1964 Mar 20;143(3612):1340–1341. doi: 10.1126/science.143.3612.1340. [DOI] [PubMed] [Google Scholar]
KAGAN G. Ia. [The problem of pathogenicity of L-form bacteria (Review of the literature)]. Klin Med (Mosk) 1961 Mar;39:12–18. [PubMed] [Google Scholar]
LAVILLAUREIX J. Action de formes L pathogènes sur des cultures de cellules cancéreuses. C R Hebd Seances Acad Sci. 1957 Feb 18;244(8):1098–1101. [PubMed] [Google Scholar]
LINDEMEYER R. I., TURCK M., PETERSDORF R. G. Factors determining the outcome of chemotherapy in infections of the urinary tract. Ann Intern Med. 1963 Feb;58:201–216. doi: 10.7326/0003-4819-58-2-201. [DOI] [PubMed] [Google Scholar]
Lederberg J. BACTERIAL PROTOPLASTS INDUCED BY PENICILLIN. Proc Natl Acad Sci U S A. 1956 Sep;42(9):574–577. doi: 10.1073/pnas.42.9.574. [DOI] [PMC free article] [PubMed] [Google Scholar]
RAZIN S., ARGAMAN M. Lysis of Mycoplasma, bacterial protoplasts, spheroplasts and L-forms by various agents. J Gen Microbiol. 1963 Jan;30:155–172. doi: 10.1099/00221287-30-1-155. [DOI] [PubMed] [Google Scholar]
VOUREKA A. Bacterial variants in patients treated with chloramphenicol. Lancet. 1951 Jan 6;1(6645):27–28. doi: 10.1016/s0140-6736(51)93498-8. [DOI] [PubMed] [Google Scholar]
WARD J. R., MADOFF S., DIENES L. In vitro sensitivity of some bacteria, their L forms and pleuropneumonia-like organisms to antibiotics. Proc Soc Exp Biol Med. 1958 Jan;97(1):132–135. doi: 10.3181/00379727-97-23667. [DOI] [PubMed] [Google Scholar]
WEIBULL C. The isolation of protoplasts from Bacillus megaterium by controlled treatment with lysozyme. J Bacteriol. 1953 Dec;66(6):688–695. doi: 10.1128/jb.66.6.688-695.1953. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES